Published on 1 Dec 2023 on GuruFocus.com via Yahoo Finance
In the realm of stock market movements, insider trading can provide valuable insights into a company's health and future prospects. When a company's Chief Financial Officer (CFO) makes a significant purchase of its stock, investors take notice. This is the case with Michael Golembiewski, CFO of Seelos Therapeutics Inc (NASDAQ:SEEL), who recently bought 83,000 shares of the company on November 30, 2023.
Who is Michael Golembiewski?
Warning! GuruFocus has detected 2 Warning Signs with SEEL.